Submit Deal

ALEXANDRIA VENTURE INVESTMENTS

HQ - Pasadena

Summary

Alexandria Venture Investments provides long-term strategic investment capital to innovative life science, technology, and agtech entities developing breakthrough technologies and therapies.

Deals Overview

Total Deals53

Valued Deals53

Total Value£ 7.91 B

Avg. Deal Size£ 149 M

Market Context

Senior Management

Peter Moglia
CEO
Stephen Richardson
CEO
Peter M. Moglia
CEO and Co-CIO

Sort

26 May 2020|United States|Medical Services

Target: INSITRO

Bidder: ALEXANDRIA VENTURE INVESTMENTS

16 Service Providers

3 Target | 13 Bidder

38 Dealmakers

4 Target | 34 Bidder

£ 116 M

Value

23 Jun 2020|United States|Biotechnology

Target: OLIVIA VENTURES INC

Bidder: COMPASS THERAPEUTICS INC

13 Service Providers

6 Target | 3 Bidder | 4 Vendor

9 Dealmakers

3 Target | 3 Bidder | 4 Vendor

£ 48 M

Value

16 Dec 2020|United States|Biotechnology

Target: NEUROGENE INC

Bidder: CASDIN CAPITAL

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

17 Feb 2021|United States|Biotechnology

Target: HUMACYTE

Bidder: ALPHA HEALTHCARE ACQUISITION

22 Service Providers

4 Target | 18 Bidder

48 Dealmakers

29 Target | 19 Bidder

£ 618 M

Value

15 Mar 2021|United States|Medical Services

Target: INSITRO

Bidder: BLACKROCK

13 Service Providers

3 Target | 10 Bidder

27 Dealmakers

3 Target | 24 Bidder

£ 287 M

Value

15 Apr 2021|United States|Biotechnology

Target: C2I GENOMICS

Bidder: THE MARK FOUNDATION FOR CANCER RESEARCH

11 Service Providers

1 Target | 10 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 72 M

Value

28 Apr 2021|United States|Biotechnology

Target: BOUNDLESS BIO

Bidder: WELLINGTON MANAGEMENT

15 Service Providers

3 Target | 12 Bidder

16 Dealmakers

4 Target | 12 Bidder

£ 75 M

Value

06 May 2021|United States|Biotechnology

Target: JASPER THERAPEUTICS INC

Bidder: AMPLITUDE HEALTHCARE ACQUISITION CORPORATION

12 Service Providers

7 Target | 5 Bidder

32 Dealmakers

29 Target | 3 Bidder

£ 350 M

Value

12 May 2021|United States|Food Products

Target: INARI

Bidder: G SQUARED

7 Service Providers

1 Target | 6 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 147 M

Value

27 May 2021|United States|Biotechnology

Target: EFFECTOR THERAPEUTICS

Bidder: LOCUST WALK ACQUISITION CORP

21 Service Providers

7 Target | 14 Bidder

33 Dealmakers

23 Target | 10 Bidder

£ 296 M

Value

16 Jun 2021|France|Biotechnology

Target: MNEMO THERAPEUTICS

Bidder: EMERSON COLLECTIVE LLC

5 Service Providers

1 Target | 4 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 63 M

Value

15 Jun 2021|United States|Biotechnology

Target: UMOJA BIOPHARMA

Bidder: CORMORANT ASSET MANAGEMENT

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

1 Target | 13 Bidder

£ 148 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy